News, Events, and Updates

News 04/08/2014

Identifying Patients Who Respond to Immunomodulator MK-3475

The data are very early, but researchers are cautiously optimistic that they have discovered a way to predict which patients will respond to the investigational immunotherapy MK-3475 (pembrolizumab, under development by Merck & Co.), which has shown promising activity in non-small cell lung cancer (NSCLC) and melanoma. April 8, 2014

News 04/04/2014

Genetic Testing Beneficial in Melanoma Treatment

Genetic screening of cancer can help doctors customize treatments so that patients with melanoma have the best chance of beating it, according to the results of a clinical trial by researchers at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter. April 4, 2014

News 04/04/2014

Melanoma’s Sugar Addiction Offers Hope For New Treatment

Melanoma cells are dependent on glucose to grow and spread, Melbourne researchers have found, paving the way for therapies that can halt cancer growth by blocking its fuel source. April 4, 2014

News 04/03/2014

Drug Is Identified That Could Block the Spread of Melanoma

New research at Rockefeller has now identified a promising route to slowing or even preventing the metastasis of melanoma cells-something no current therapy can effectively accomplish. April 3, 2014

News 03/31/2014

Genetic Mutations That Up Skin Cancer Risk Identified

Researchers have discovered that mutations in a specific gene are responsible for a hereditary form of melanoma, a type of skin cancer. March 31, 2014

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.